scholarly journals FDG–PET for assessment of early treatment response after four cycles of chemotherapy in patients with advanced-stage Hodgkin's lymphoma has a high negative predictive value

2009 ◽  
Vol 20 (7) ◽  
pp. 1270-1274 ◽  
Author(s):  
J. Markova ◽  
C. Kobe ◽  
M. Skopalova ◽  
K. Klaskova ◽  
K. Dedeckova ◽  
...  
2008 ◽  
Vol 47 (06) ◽  
pp. 235-238 ◽  
Author(s):  
M. Dietlein ◽  
C. Mauz-Körholz ◽  
A. Engert ◽  
P. Borchmann ◽  
O. Sabri ◽  
...  

SummaryThe high negative predictive value of FDG-PET in therapy control of Hodgkin lymphoma is proven by the data acquired up to now. Thus, the analysis of the HD15 trial has shown that consolidation radiotherapy might be omitted in PET negative patients after effective chemotherapy. Further response adapted therapy guided by PET seems to be a promising approach in reducing the toxicity for patients undergoing chemotherapy. The criteria used for the PET interpretation have been standardized by the German study groups for Hodgkin lymphoma patients and will be reevaluated in the current studies.


PLoS ONE ◽  
2017 ◽  
Vol 12 (5) ◽  
pp. e0177997 ◽  
Author(s):  
Kamilla Norregaard ◽  
Jesper T. Jørgensen ◽  
Marina Simón ◽  
Fredrik Melander ◽  
Lotte K. Kristensen ◽  
...  

2017 ◽  
Author(s):  
Jesper Tranekjaer Joergensen ◽  
Kamilla Norregaard ◽  
Marina Simón Martín ◽  
Fredrik Melander ◽  
Lotte K. Kristensen ◽  
...  

2014 ◽  
Vol 111 ◽  
pp. S45
Author(s):  
S. Carvalho ◽  
R. Leijenaar ◽  
E. Rios Velazquez ◽  
W. Van Elmpt ◽  
C. Oberije ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document